Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3949/ccjm.87a.ccc023 http://scihub22266oqcxt.onion/10.3949/ccjm.87a.ccc023 32393597!ä!32393597 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cleve+Clin+J+Med 2020 ; ä (ä): ä Nephropedia Template TP {{tp|p=32393597|t=2020. Keeping lupus patients on hydroxychloroquine during the COVID-19 pandemic |pdf=|usr=}}{{32393597}} gab.com Text Keeping lupus patients on hydroxychloroquine during the COVID-19 pandemic JO: Cleve Clin J Med http://www.kidney.de/pget.php?&tw=1&pmid=32393597 #FOAvip Hydroxychloroquine (HCQ) is in short supply as a result of the coronavirus disease 2019 (COVID-19) pandemic, presenting a challenge to rheumatologists to ensure their patients with systemic lupus erythematosus (SLE) continue to take this essential drug. HCQ is the only SLE treatment shown to increase survival and any change in the HCQ regimen is potentially dangerous. Changes in the HCQ regimen should be made jointly with the patient after a discussion of the available evidence and expert opinion and the patient's preferences. Providers need to make thoughtful, informed decisions in this time of medication shortage. Twit Text FOAVip Keeping lupus patients on hydroxychloroquine during the COVID-19 pandemic ????Cleve Clin J Med http://www.kidney.de/pget.php?&tw=1&pmid=32393597 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32393597 #FOAvip English Wikipedia <ref>{{Cite pmid|32393597}}</ref> Keeping lupus patients on hydroxychloroquine during the COVID-19 pandemic #MMPMID32393597 Littlejohn E Cleve Clin J Med 2020[May]; ä (ä): ä PMID32393597show ga Hydroxychloroquine (HCQ) is in short supply as a result of the coronavirus disease 2019 (COVID-19) pandemic, presenting a challenge to rheumatologists to ensure their patients with systemic lupus erythematosus (SLE) continue to take this essential drug. HCQ is the only SLE treatment shown to increase survival and any change in the HCQ regimen is potentially dangerous. Changes in the HCQ regimen should be made jointly with the patient after a discussion of the available evidence and expert opinion and the patient's preferences. Providers need to make thoughtful, informed decisions in this time of medication shortage. äKeeping lupus patients on hydroxychloroquine during the COVID-19 pande(epmc).pdf DeepDyve Pubget Overpricing